Lumexa Imaging (NASDAQ:LMRI) Stock Price Up 10% – Here’s What Happened

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI)’s share price rose 10% during trading on Thursday . The stock traded as high as $8.11 and last traded at $8.2610. Approximately 18,410 shares traded hands during trading, a decline of 98% from the average daily volume of 873,506 shares. The stock had previously closed at $7.51.

Wall Street Analysts Forecast Growth

LMRI has been the subject of several recent analyst reports. Barclays reduced their target price on Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating for the company in a research report on Wednesday, May 20th. Raymond James Financial upgraded Lumexa Imaging from an “outperform” rating to a “strong-buy” rating and set a $23.00 target price for the company in a research report on Monday, February 9th. Finally, Weiss Ratings upgraded Lumexa Imaging from a “sell (e-)” rating to a “sell (e)” rating in a research report on Monday. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $16.00.

Lumexa Imaging Stock Up 3.2%

The firm has a fifty day moving average price of $8.78.

Insider Activity

In other news, Director Brett Brodnax acquired 35,000 shares of the business’s stock in a transaction dated Tuesday, May 19th. The stock was purchased at an average cost of $7.25 per share, for a total transaction of $253,750.00. Following the acquisition, the director owned 62,027 shares of the company’s stock, valued at $449,695.75. This trade represents a 129.50% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.70% of the company’s stock.

Hedge Funds Weigh In On Lumexa Imaging

Hedge funds and other institutional investors have recently modified their holdings of the company. Assetmark Inc. purchased a new position in shares of Lumexa Imaging in the 4th quarter worth about $36,000. Strs Ohio purchased a new position in shares of Lumexa Imaging in the 1st quarter worth about $38,000. Barclays PLC purchased a new position in shares of Lumexa Imaging in the 4th quarter worth about $133,000. PNC Financial Services Group Inc. purchased a new position in shares of Lumexa Imaging in the 1st quarter worth about $63,000. Finally, Sandia Investment Management LP purchased a new position in shares of Lumexa Imaging in the 4th quarter worth about $185,000.

Lumexa Imaging Company Profile

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).